These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 37024667)

  • 21. Association between ERCC1 and XPA expression and polymorphisms and the response to cisplatin in testicular germ cell tumours.
    Mendoza J; Martínez J; Hernández C; Pérez-Montiel D; Castro C; Fabián-Morales E; Santibáñez M; González-Barrios R; Díaz-Chávez J; Andonegui MA; Reynoso N; Oñate LF; Jiménez MA; Núñez M; Dyer R; Herrera LA
    Br J Cancer; 2013 Jul; 109(1):68-75. PubMed ID: 23807173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Seladin-1 and testicular germ cell tumours: new insights into cisplatin responsiveness.
    Nuti F; Luciani P; Marinari E; Erdei E; Bak M; Deledda C; Rosati F; Mazzinghi B; Danza G; Stoop H; Looijenga LH; Peri A; Serio M; Krausz C
    J Pathol; 2009 Dec; 219(4):491-500. PubMed ID: 19844922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reciprocal epigenetic remodeling controls testicular cancer hypersensitivity to hypomethylating agents and chemotherapy.
    Singh R; Fazal Z; Bikorimana E; Boyd RI; Yerby C; Tomlin M; Baldwin H; Shokry D; Corbet AK; Shahid K; Hattab A; Freemantle SJ; Spinella MJ
    Mol Oncol; 2022 Feb; 16(3):683-698. PubMed ID: 34482638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Testis-expressed gene 11 inhibits cisplatin-induced DNA damage and contributes to chemoresistance in testicular germ cell tumor.
    Kitayama S; Ikeda K; Sato W; Takeshita H; Kawakami S; Inoue S; Horie K
    Sci Rep; 2022 Nov; 12(1):18423. PubMed ID: 36319719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The attractive Achilles heel of germ cell tumours: an inherent sensitivity to apoptosis-inducing stimuli.
    Spierings DC; de Vries EG; Vellenga E; de Jong S
    J Pathol; 2003 Jun; 200(2):137-48. PubMed ID: 12754734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential New Therapeutic Approaches for Cisplatin-Resistant Testicular Germ Cell Tumors.
    Lengert AVH; Pereira LDNB; Cabral ERM; Gomes INF; Jesus LM; Gonçalves MFS; Rocha AOD; Tassinari TA; Silva LSD; Laus AC; Vidal DO; Pinto MT; Reis RM; Lopes LF
    Front Biosci (Landmark Ed); 2022 Aug; 27(8):245. PubMed ID: 36042160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relative activity of cisplatin, oxaliplatin and satraplatin in testicular germ cell tumour sensitive and resistant cell lines.
    Perry J; Powles T; Shamash J; Veerupillai A; McGrowder E; Noel E; Lu YJ; Oliver T; Joel S
    Cancer Chemother Pharmacol; 2009 Oct; 64(5):925-33. PubMed ID: 19263053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression and roles of system L amino acid transporters in human embryonal carcinoma cells.
    Chatsirisupachai K; Kitdumrongthum S; Panvongsa W; Janpipatkul K; Worakitchanon W; Lertjintanakit S; Wongtrakoongate P; Chairoungdua A
    Andrology; 2020 Nov; 8(6):1844-1858. PubMed ID: 32741077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CDK4/6 inhibition presents as a therapeutic option for paediatric and adult germ cell tumours and induces cell cycle arrest and apoptosis via canonical and non-canonical mechanisms.
    Skowron MA; Vermeulen M; Winkelhausen A; Becker TK; Bremmer F; Petzsch P; Schönberger S; Calaminus G; Köhrer K; Albers P; Nettersheim D
    Br J Cancer; 2020 Aug; 123(3):378-391. PubMed ID: 32418994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cisplatin Cytotoxicity in Human Testicular Germ Cell Tumor Cell Lines Is Enhanced by the CDK4/6 Inhibitor Palbociclib.
    Rossini E; Bosatta V; Abate A; Fragni M; Salvi V; Basnet RM; Zizioli D; Bosisio D; Piovani G; Valcamonico F; Mirabella G; Berruti A; Memo M; Sigala S
    Clin Genitourin Cancer; 2021 Aug; 19(4):316-324. PubMed ID: 33676835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clonal analyses of refractory testicular germ cell tumors.
    Barrett MT; Lenkiewicz E; Malasi S; Stanton M; Slack J; Andrews P; Pagliaro L; Bryce AH
    PLoS One; 2019; 14(3):e0213815. PubMed ID: 30870501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of N-cadherin in proliferation, migration, and invasion of germ cell tumours.
    Bremmer F; Schallenberg S; Jarry H; Küffer S; Kaulfuss S; Burfeind P; Strauß A; Thelen P; Radzun HJ; Ströbel P; Honecker F; Behnes CL
    Oncotarget; 2015 Oct; 6(32):33426-37. PubMed ID: 26451610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of targeted drugs in germ cell cancer cell lines with differential cisplatin sensitivity.
    Schaffrath J; Schmoll HJ; Voigt W; Müller LP; Müller-Tidow C; Mueller T
    PLoS One; 2017; 12(6):e0178930. PubMed ID: 28591197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic drugs and their molecular targets in testicular germ cell tumours.
    Jostes S; Nettersheim D; Schorle H
    Nat Rev Urol; 2019 Apr; 16(4):245-259. PubMed ID: 30765888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Revisiting DNA damage repair, p53-mediated apoptosis and cisplatin sensitivity in germ cell tumors.
    Cavallo F; Feldman DR; Barchi M
    Int J Dev Biol; 2013; 57(2-4):273-80. PubMed ID: 23784838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-302a sensitizes testicular embryonal carcinoma cells to cisplatin-induced cell death.
    Liu L; Lian J; Zhang H; Tian H; Liang M; Yin M; Sun F
    J Cell Physiol; 2013 Dec; 228(12):2294-304. PubMed ID: 23625774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cisplatin hypersensitivity of testicular germ cell tumors is determined by high constitutive Noxa levels mediated by Oct-4.
    Gutekunst M; Mueller T; Weilbacher A; Dengler MA; Bedke J; Kruck S; Oren M; Aulitzky WE; van der Kuip H
    Cancer Res; 2013 Mar; 73(5):1460-9. PubMed ID: 23302226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel sequential therapy with metformin enhances the effects of cisplatin in testicular germ cell tumours via YAP1 signalling.
    He K; Li Z; Ye K; Zhou Y; Yan M; Qi H; Hu H; Dai Y; Tang Y
    Cancer Cell Int; 2022 Mar; 22(1):113. PubMed ID: 35264157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteomic profiling of cisplatin-resistant and cisplatin-sensitive germ cell tumour cell lines using quantitative mass spectrometry.
    Fichtner A; Bohnenberger H; Elakad O; Richter A; Lenz C; Oing C; Ströbel P; Kueffer S; Nettersheim D; Bremmer F
    World J Urol; 2022 Feb; 40(2):373-383. PubMed ID: 35084545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular portrait of cisplatin induced response in human testis cancer cell lines based on gene expression profiles.
    Duale N; Lindeman B; Komada M; Olsen AK; Andreassen A; Soderlund EJ; Brunborg G
    Mol Cancer; 2007 Aug; 6():53. PubMed ID: 17711579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.